Stress, Distress Intolerance, and Drug Dependence



Status:Completed
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 70
Updated:10/14/2017
Start Date:June 2005
End Date:July 2011

Use our guide to learn which trials are right for you!

This study is designed to evaluate the relative efficacy of a novel treatment (CBT-IC) versus
a standard individual drug-counseling treatment. The novel treatment emphasizes exposure to
emotional cues for drug use as part of a comprehensive, yet brief, treatment strategy. These
treatments are delivered to opiate-dependent, often poly-substance dependent, individuals in
a comprehensive methadone maintenance program who have failed to respond adequately to
current treatments.


Inclusion Criteria:

- The primary selection criteria include women and men between the ages of 18 and 65
who:

1. Meet DSM-IV criteria for opiate dependence,

2. Maintain a stable dose of methadone for two weeks prior to recruitment and,

3. a) fail to achieve "take-home" status for methadone dosing during at least the
first four months of methadone treatment, b) test positive on at least two
toxicology screens for illicit drugs during the month prior to recruitment c)
have never achieved two consecutive toxicology screens free of illicit substances
since entering the current treatment episode.

4. Meet study criteria for chronic stress

1. unemployment criteria, and

2. affective disorder criteria.

Exclusion Criteria:

- (1) Patients with significantly unstable or uncontrolled medical illness which may
interfere with participation in treatment (e.g., patients likely to require
hospitalization during the study period).

(2) Patients with a psychotic or organic mental disorder according to DSM-IV criteria.

(3) Patients receiving medication affecting methadone metabolism (e.g. rifampin).

(4) Patients with uncontrolled bipolar disorder as evidenced by meeting current
criteria for mania or hypomania or meeting criteria for rapid cycling in the last year
(as indicated by structured questioning of all patients meeting criteria for bipolar
disorder).

(5) Patients unable to complete the informed consent or unable to understand study
procedures in the informed consent process.
We found this trial at
2
sites
Boston, Massachusetts 02118
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boston, Massachusetts 02114
?
mi
from
Boston, MA
Click here to add this to my saved trials